WATCH LIVE: Day 2 of FDA advisory panel meeting to consider use of peptides
FDA / PCAC — official records & coverage — WATCH LIVE: Day 2 of FDA advisory panel meeting to consider use of peptides
Channel: PBS NewsHour · Our label: Government proceedings and coverage of them · Source: youtube.com/watch?v=ckMZ7z5W_Uw
What this video covers
Okay, good morning every state, so let’s get going now. Welcome for you, the city, the city, welcome out. First I’d like to want to please you about speaking in a public phone. I’ve always wanted to be my voice of fame for this workshop.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Real-world evidence is the clinical evidence about usage and potential benefits or risks of a medical product derived from analysis of real-world data.
- If you are interested in further information, we have guidance documents, compounding risk alerts, compounding inspections and recall information, and information provided by our compounding quality center of excellence.
- In addition, the nominator did not submit and FDA did not identify in the literature non-clinical toxicity studies to inform safety considerations for potential clinical uses of amidaletide-related BDSs.
- Combined with careful clinical protocols and the oversight of licensed clinicians, we believe doctors should not be prevented from accessing the clinical potential of epitalon.
- Compounding with epitalone can be traced back to at least 2018 when a compounding pharmacy and its owner were sentenced for unlawful distribution of compounded prescription drugs, including epitalone.
- We saw in the clinical studies that much higher doses are used in clinical practice if those doses are reflecting clinical practice and higher doses were also used in the published clinical studies.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.